Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gavine PR"'
Publikováno v:
OncoTargets and Therapy, Vol 2015, Iss default, Pp 7-14 (2014)
Daoqiang Tang,1 Charles YJ Liu,2 Danping Shen,3 Shuqiong Fan,2 Xinying Su,2 Peng Ye,2 Paul R Gavine,2 Xiaolu Yin2 1Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 2Department of Translational Science, Asia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::9c34fa2cc08c990a6783a2b15eac1317
http://www.dovepress.com/assessment-and-prognostic-analysis-of-egfr-her2-and-her3-protein-expre-peer-reviewed-article-OTT
http://www.dovepress.com/assessment-and-prognostic-analysis-of-egfr-her2-and-her3-protein-expre-peer-reviewed-article-OTT
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jiang L; Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Su X; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Zhang T; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Yin X; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Zhang M; R&D Information, AstraZeneca, Shanghai, China., Fu H; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Han H; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Sun Y; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Dong L; Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Qian J; Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Xu Y; Global Medicines Development, AstraZeneca, Shanghai, China., Fu X; Global Medicines Development, AstraZeneca, Shanghai, China., Gavine PR; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China., Zhou Y; The First Affiliated Hospital, Sun Yat-Sen University, Guangdong, China., Tian K; General Hospital of Chengdu Military Region of PLA, Sichuan, China., Huang J; R&D, MedImmune, AstraZeneca, Gaithersburg, MD, USA., Shen D; R&D, MedImmune, AstraZeneca, Gaithersburg, MD, USA., Jiang H; Global Medicines Development, AstraZeneca, Shanghai, China., Yao Y; R&D, MedImmune, AstraZeneca, Gaithersburg, MD, USA., Han B; Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Gu Y; Asia & Emerging Markets, iMed, AstraZeneca, Shanghai, China.
Publikováno v:
Oncotarget [Oncotarget] 2017 Apr 18; Vol. 8 (16), pp. 26845-26857.
Autor:
Chen H; Chemistry Innovation Centre, Discovery Sciences, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Tucker J; Structure and Biophysics, Discovery Sciences, AstraZeneca R&D Alderley Park, Macclesfield SK10 4TG, England., Wang X; Innovation Centre China, AstraZeneca Asia and Emerging Markets iMed, Shanghai 201203, People's Republic of China., Gavine PR; Innovation Centre China, AstraZeneca Asia and Emerging Markets iMed, Shanghai 201203, People's Republic of China., Phillips C; Structure and Biophysics, Discovery Sciences, AstraZeneca R&D Alderley Park, Macclesfield SK10 4TG, England., Augustin MA; Proteros biostructures GmbH, Bunsenstrasse 7a, 82152 Martinsried, Germany., Schreiner P; Proteros biostructures GmbH, Bunsenstrasse 7a, 82152 Martinsried, Germany., Steinbacher S; Proteros biostructures GmbH, Bunsenstrasse 7a, 82152 Martinsried, Germany., Preston M; Screening Sciences, Discovery Sciences, AstraZeneca R&D Alderley Park, Macclesfield SK10 4TG, England., Ogg D; Structure and Biophysics, Discovery Sciences, AstraZeneca R&D Alderley Park, Macclesfield SK10 4TG, England.
Publikováno v:
Acta crystallographica. Section D, Structural biology [Acta Crystallogr D Struct Biol] 2016 May; Vol. 72 (Pt 5), pp. 682-93. Date of Electronic Publication: 2016 Apr 26.
Autor:
Yin X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Zhang T; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Su X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Ji Y; Research & Development Information, AstraZeneca R&D, Shanghai, China., Ye P; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Fu H; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Fan S; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Shen Y; Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Gavine PR; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Gu Y; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China.
Publikováno v:
PloS one [PLoS One] 2015 Dec 04; Vol. 10 (12), pp. e0143468. Date of Electronic Publication: 2015 Dec 04 (Print Publication: 2015).
Autor:
Ye P; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Zhang M; Research & Development Information, AstraZeneca R&D, Shanghai, China., Fan S; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Zhang T; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Fu H; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Su X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Gavine PR; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China., Liu Q; Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Yin X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, China.
Publikováno v:
PloS one [PLoS One] 2015 Nov 20; Vol. 10 (11), pp. e0143207. Date of Electronic Publication: 2015 Nov 20 (Print Publication: 2015).
Autor:
Zhang T; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Zhang L; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Fan S; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Zhang M; Research and Development Information, AstraZeneca R&D, Shanghai, P.R. China., Fu H; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Liu Y; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Yin X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Chen H; Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China., Xie L; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Zhang J; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Gavine PR; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Gu Y; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China., Ni X; Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China., Su X; Asia & Emerging Markets iMed, AstraZeneca R&D, Shanghai, P.R. China.
Publikováno v:
PloS one [PLoS One] 2015 Jul 28; Vol. 10 (7), pp. e0134493. Date of Electronic Publication: 2015 Jul 28 (Print Publication: 2015).
Autor:
Gavine PR; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Paul.gavine@astrazeneca.com., Wang M; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Mei.wang@astrazeneca.com., Yu D; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. yudehua@yahoo.com., Hu E; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. eva.hu@astrazeneca.com., Huang C; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. chunlei.huang@astrazeneca.com., Xia J; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. jenny.xia@astrazeneca.com., Su X; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Xinying.su@astrazeneca.com., Fan J; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. joan.fan@astrazeneca.com., Zhang T; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Tianwei.zhang@astrazeneca.com., Ye Q; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. yeqingqing616@163.com., Zheng L; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Li.zheng@astrazeneca.com., Zhu G; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Guanshan_zhu@hotmail.com., Qian Z; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. zl_qian@aliyun.com., Luo Q; Shanghai Chest Hospital, Shanghai, People's Republic of China. luoqingquan@hotmail.com., Hou YY; Shanghai Zhongshan Hospital, Shanghai, People's Republic of China. houyingyong@medmail.com.cn., Ji Q; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, 201203, People's Republic of China. Qunsheng.ji@astrazeneca.com.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Jun 04; Vol. 15, pp. 454. Date of Electronic Publication: 2015 Jun 04.
Autor:
Gavine PR; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China. Electronic address: paul.gavine@astrazeneca.com., Ren Y; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Han L; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Lv J; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Fan S; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Zhang W; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Xu W; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Liu YJ; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Zhang T; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Fu H; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Yu Y; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Wang H; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Xu S; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Zhou F; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Su X; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Yin X; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Xie L; AstraZeneca, Asia & Emerging Markets iMed, AstraZeneca Global R&D, 199 LiangJing Road, ZhangJiang Hi-Tech Park, Shanghai, China., Wang L; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Qing W; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Jiao L; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Su W; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China., Wang QM; Hutchison Medi Pharma Ltd, 720 Cai Lun Road, Zhangjiang Hi-Tech Park, Shanghai, China.
Publikováno v:
Molecular oncology [Mol Oncol] 2015 Jan; Vol. 9 (1), pp. 323-33. Date of Electronic Publication: 2014 Sep 10.
Autor:
Zhang J; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Jiang D; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Li X; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Lv J; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Xie L; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Zheng L; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Gavine PR; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Hu Q; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Shi Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Tan L; Department of Thorax Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Ge D; Department of Thorax Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Xu S; Department of Thorax Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Li L; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Zhu L; Innovation Center China, AstraZeneca Global R&D, Zhangjiang Hi-Tech Park, Shanghai, People's Republic of China., Hou Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China., Wang Q; Department of Thorax Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2014 Aug; Vol. 94 (8), pp. 917-26. Date of Electronic Publication: 2014 Jul 07.